🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Von Willebrand Diseases

External Multicenter Validation of the APTTO Model for Prolonged APTT Using Clot Waveform Analysis NCT07418099n/a16 sites📍 Leganés📍 Barcelona📍 Lleida Instituto de Investigación Sanitaria de la Fundación Jiméne… · Tests: Clot waveform analysis-based risk stratification (APTTO models) Cardiovascular and Venous Thromboembolism Disease in Patients with Von Willebrand Disease in the French West NCT05773638n/a6 sites📍 Angers📍 Brest📍 Caen University Hospital, Brest Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty. NCT07582835Phase 31 site📍 Lugano Cardiocentro Ticino · Tests: Clopidogrel, Ticagrelor, Prasugrel The Severe Von Willebrand Disease (sVWD) Patient Registry NCT05437536n/a1 site📍 Wellington VWD Connect Foundation Von Willebrand Factor in Pregnancy (VIP) Study NCT04146376n/a11 sites📍 Aurora📍 New Haven📍 Miami University of Washington · Tests: Use of a postpartum diary and additional blood draws, VWF replacement therapy with Wilate, Tranexamic acid, Use of a po… A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD) NCT05582993Phase 323 sites📍 Birmingham📍 Orlando📍 Peoria Takeda · Tests: Vonicog Alfa, ADVATE ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders NCT04398628n/a76 sites📍 Phoenix📍 Little Rock📍 Los Angeles American Thrombosis and Hemostasis Network A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease NCT06998524Phase 329 sites📍 Sacramento📍 Gainesville📍 Lexington Hoffmann-La Roche · Tests: Emicizumab, von Willebrand Factor (VWF) Concentrates, Factor VIII (FVIII) Concentrates, von Willebrand Factor (VWF) and… HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMB NCT07575308Phase 221 sites📍 Orange📍 San Diego📍 San Francisco Alnylam Pharmaceuticals · Tests: ALN-6400 Endothelial Colony-Forming Cells in Patients With VWD, AVWS and Healthy Subjects NCT07358013n/a1 site📍 Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Tests: Blood sample collection for VWF measurements in plasma, Blood sample collection for ECFC isolation and characterization… Blood Clotting Markers and Heart Ultrasound in People With Device-Detected Atrial Fibrillation NCT07713615n/a1 site📍 Esbjerg Andreas Sjøholm-Christensen World Bleeding Disorders Registry NCT03327779n/a1 site📍 Montreal World Federation of Hemophilia A Study Assessing HMB-002 in Participants With Von Willebrand Disease NCT06754852Phase 1, Phase 225 sites📍 Phoenix📍 Little Rock📍 Los Angeles Hemab ApS · Tests: HMB-002 (Part A), HMB-002 (Part B), HMB-002 with Concomitant Factor Concentrate (Part C) (Not Applicable in US) A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients With VWD NCT06205095Phase 32 sites📍 Kingston📍 Toronto Unity Health Toronto · Tests: Lyophilized concentrate of human coagulation von Willebrand Factor and factor VIII, Placebo Severe Congenital Hemostatic Defects, Cerebral MIcrobleeds and COGnition NCT06090201n/a1 site📍 Lille University Hospital, Lille · Tests: 3-Tesla brain MRI and a comprehensive neuropsychological assessment ATHNdataset Registry NCT06820515n/a1 site📍 Hickory American Thrombosis and Hemostasis Network Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand Disease NCT06651255NA17 sites📍 Lille📍 Tours📍 Amiens University Hospital, Lille · Tests: Optimized management, Standard of care management Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD) NCT07115004Phase 332 sites📍 Little Rock📍 Los Angeles📍 Palo Alto Vega Therapeutics, Inc · Tests: VGA039 Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow Conditions NCT03773159n/a2 sites📍 Besançon📍 Dijon Centre Hospitalier Universitaire Dijon · Tests: Blood sampling Exploration of Systemic and Portal Hemostasis in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Placement NCT07439939n/a1 site📍 Villejuif Assistance Publique - Hôpitaux de Paris Recombinant vWF Concentrate and ECMO NCT06118372Phase 11 site📍 Charlottesville University of Virginia · Tests: Recombinant von Willebrand Factor A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD) NCT07129343Phase 37 sites📍 Beijing📍 Guangzhou📍 Jihan Takeda · Tests: VONVENDI, ADVATE Von Willebrand Factor Point-of-care Testing to Improve Minimally Invasive TAVI Outcomes NCT03728049NA9 sites📍 Clermont-Ferrand📍 Lille📍 Montpellier University Hospital, Lille · Tests: CT-ADP performed during TAVI procedure, No CT-ADP performed during TAVI procedure Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID) NCT05776069Phase 1, Phase 225 sites📍 Los Angeles📍 Sacramento📍 Aurora Vega Therapeutics, Inc · Tests: VGA039, Placebo, VGA039 A Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of SR604 Injection in Patients With Von Willebrand Disease NCT07640893Phase 29 sites📍 Changsha📍 Hefei📍 Jinan Shanghai RAAS Blood Products Co., Ltd. · Tests: SR604 A Study of Bleeding and Treatment in Participants With Von Willebrand Disease NCT06610201n/a17 sites📍 Phoenix📍 Little Rock📍 Los Angeles Hemab ApS · Tests: Clinical outcomes of patients with VWD, Type 1, Clinical outcomes of patients with VWD, Type 2A, Type 2M, Type 2N, or T… Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A NCT05500807Phase 112 sites📍 Orange📍 Redwood City📍 Coral Gables Bleeding and Clotting Disorders Institute Peoria, Illinois · Tests: Emicizumab Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome) NCT01257269n/a7 sites📍 Oklahoma City📍 Vienna📍 Prague Insel Gruppe AG, University Hospital Bern · Tests: Observation Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study NCT05916469n/a9 sites📍 Palo Alto📍 Aurora📍 Atlanta Oregon Health and Science University · Tests: Levonorgestrel Intrauterine System, Norethindrone Acetate Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases NCT04119908NA1 site📍 Lille University Hospital, Lille · Tests: Sublingual videomicroscopy, blood sample
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy